Urology of Virginia

Urology of Virginia has provided comprehensive urological care in Hampton Roads for nearly 100 years. Founded in 1922 by Charles Devine, the practice began growing in the 1950s. The practice gained an international reputation for genitourinary reconstructive surgery, developing new surgical techniques to correct urethral strictures and hypospadias that are still used today. In 1965, Urology of Virginia became one of the few private practices in the country to have a residency program. In the 1970s, we were instrumental in helping establish Eastern Virginia Medical School, Norfolk, Virginia, serving as faculty and becoming one of the first established EVMS departments.

Get in Touch

We are here to help you in anyway. Feel free to click the button below to see contact options.

Contact Us Now!
Inactivity, Sitting Tied to LUTS in Men

Inactivity, Sitting Tied to LUTS in Men

(HealthDay News) -- Prolonged sitting time and low physical activity levels are tied to higher incidence of lower urinary tract symptoms (LUTS) in men, according to a study...

Metabolic Syndrome, Smoking Up Nocturia Risk in BPH

Metabolic Syndrome, Smoking Up Nocturia Risk in BPH

SAN FRANCISCO—Moderate or severe nocturia is more like to develop in men following transurethral resection of the prostate (TURP) for benign prostatic hyperplasia if they smoke...

New LUTS Classification for Women Proposed

New LUTS Classification for Women Proposed

Women seeking care for lower urinary tract symptoms (LUTS) cluster into 4 distinct symptom groups that differ from conventional clinical diagnostic groups, investigators...

Biopsy, Pathology Results Often Differ in UTUC

Biopsy, Pathology Results Often Differ in UTUC

Investigators have identified discrepancies between biopsy and final pathology results from upper tract urothelial carcinoma (UTUC) patients that, if confirmed, have important...

Model Predicts Survival in Urothelial Cancer With Immunotherapy

Model Predicts Survival in Urothelial Cancer With Immunotherapy

HealthDay News) -- A model has been developed to predict overall survival for patients with advanced urothelial carcinoma treated with atezolizumab, according to a presentation...

Neuropathic Detrusor Underactivity More Common in Women

Neuropathic Detrusor Underactivity More Common in Women

PHILADELPHIA—Detrusor underactivity (DU) due to neuropathic causes is more common in women than men, according to study findings presented at the International Continence...

Spermatogenesis Still Occurs in Men With Testicular Cancer

Spermatogenesis Still Occurs in Men With Testicular Cancer

(HealthDay News) -- Spermatogenesis occurs in most men with testicular cancer, often away from tumors, according to a study published online in BJU International. Jemma A....

FDA Requires Safety Label Changes for Fluoroquinolones

FDA Requires Safety Label Changes for Fluoroquinolones

(HealthDay News) -- The US Food and Drug Administration has strengthened current warnings in the prescribing information about fluoroquinolone antibiotics causing significant...

Bladder, Bowel Dysfunction More Likely in Girls vs Boys

Bladder, Bowel Dysfunction More Likely in Girls vs Boys

Female sex and dilating vesicoureteral reflux (VUR) are independent risk factors for the development of bladder and bowel dysfunction (BBD) in children, according to study...

Rise in Localized High-Risk RCC Reported

Rise in Localized High-Risk RCC Reported

Investigators who examined trends in the clinical characteristics of pathologically-confirmed high-risk renal cell carcinoma (RCC) over a 25-year period found that patients are...

Enhanced Cystoscopy Improves the Care of Bladder Cancer Patients

Enhanced Cystoscopy Improves the Care of Bladder Cancer Patients

While survival rates for the majority of patients with non-muscle invasive bladder cancer (NMIBC) are favorable, bladder cancer has a relatively high risk of disease recurrence...

Proximal PSA Predicts Prostate Cancer Metastasis Risk

Proximal PSA Predicts Prostate Cancer Metastasis Risk

Proximal PSA levels of 10 ng/mL or higher in men with biochemically recurrent prostate cancer (PCa) after radical prostatectomy and a PSA doubling time (PSADT) less than 12...